Klotho Neurosciences logo

Klotho Neurosciences Share Price (NASDAQ: KLTO)

$0.69

-0.03

(-4.17%)

Last updated on

Check the interactive Klotho Neurosciences Stock chart to analyse performance

Klotho Neurosciences stock performance

as on August 30, 2025 at 1:28 am IST

  • Today's Low:$0.69
    Today's High:$0.72

    Day's Volatility :4.86%

  • 52 Weeks Low:$0.11
    52 Weeks High:$3.91

    52 Weeks Volatility :97.1%

Klotho Neurosciences Stock Returns

PeriodKlotho Neurosciences IncIndex (Russel 2000)
3 Months
296.74%
0.0%
6 Months
136.24%
0.0%
1 Year
-25.18%
0.0%
3 Years
-92.97%
-4.7%

Klotho Neurosciences Inc Key Stats

Check Klotho Neurosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.72
Open
$0.72
Today's High
$0.72
Today's Low
$0.685
Market Capitalization
$44.5M
Today's Volume
$944.7K
52 Week High
$3.9099
52 Week Low
$0.1135
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-249.56%

Stock Returns calculator for Klotho Neurosciences Stock including INR - Dollar returns

The Klotho Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Klotho Neurosciences investment value today

Current value as on today

₹79,478

Returns

₹20,522

(-20.52%)

Returns from Klotho Neurosciences Stock

₹25,806 (-25.81%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Klotho Neurosciences Stock

-67%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Search interest for Klotho Neurosciences Stock from India on INDmoney has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Klotho Neurosciences Stock

Rating
Trend

Klotho Neurosciences Stock Insights

  • Price Movement

    In the last 3 months, KLTO stock has moved up by 281.5%
  • KLTO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 140.2%
  • KLTO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 205.6%

Klotho Neurosciences Technicals Summary

Sell

Neutral

Buy

Klotho Neurosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Klotho Neurosciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Klotho Neurosciences Inc logo
-27.96%
136.24%
-25.18%
-92.97%
-92.98%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.98%
-0.05%
-6.32%
Beone Medicines Ltd logo
1.77%
24.81%
59.79%
78.52%
26.86%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-21.18%
38.72%
40.03%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
69.91%
115.96%
236.5%

About Klotho Neurosciences Inc

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Organization
Klotho Neurosciences
Employees
3
CEO
Dr. Joseph Sinkule Pharm.D.
Industry
Miscellaneous

Key Management of Klotho Neurosciences Inc

NameTitle
Dr. Joseph Sinkule Pharm.D.
Founder, CEO, Chairman of the Board & Secretary
Mr. Jeffrey LeBlanc
Chief Financial Officer
Dr. Shalom Z. Hirschman M.D.
Medical Advisor & Director
Mr. Peter J. Moriarty
Chief Business Officer
Dr. Miguel Chillon Rodriguez
Chief Scientific Advisor & Consultant
Dr. Bradford A. Navia M.D., Ph.D.
Chief Medical Advisor

Important FAQs about investing in KLTO Stock from India :

What is Klotho Neurosciences share price today?

Klotho Neurosciences share price today is $0.69 as on at the close of the market. Klotho Neurosciences share today touched a day high of $0.72 and a low of $0.69.

What is the 52 week high and 52 week low for Klotho Neurosciences share?

Klotho Neurosciences share touched a 52 week high of $3.91 and a 52 week low of $0.11. Klotho Neurosciences stock price today i.e. is closed at $0.69, lower by 82.35% versus the 52 week high.

How to invest in Klotho Neurosciences Stock (KLTO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Klotho Neurosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Klotho Neurosciences Shares that will get you 2.1739 shares as per Klotho Neurosciences share price of $0.69 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Klotho Neurosciences Stock (KLTO) from India?

Indian investors can start investing in Klotho Neurosciences (KLTO) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Klotho Neurosciences stock (as per the Rupee-Dollar exchange rate as on August 30, 2025). Based on Klotho Neurosciences share’s latest price of $0.69 as on August 30, 2025 at 1:28 am IST, you will get 14.4928 shares of Klotho Neurosciences. Learn more about fractional shares .

What are the returns that Klotho Neurosciences has given to Indian investors in the last 5 years?

Klotho Neurosciences stock has given -92.98% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?